Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Afferent Pharmaceuticals

http://www.afferentpharma.com/

Latest From Afferent Pharmaceuticals

Time To Grow: SK Bioscience Eyes US Vaccine, CGT Acquisitions This Year

SK Bioscience CEO outlines the progress the firm is making in its growth acceleration strategy, which involves aggressive M&As and other investment plans.

South Korea Commercial

Ring Therapeutics Turns To Anelloviruses To Disrupt Gene Therapy Space

Ring Therapeutics is turning to a previously unexplored family of viruses to improve the safety and efficacy of gene therapy. The preclinical science suggests using these anelloviruses as vectors can deliver payloads precisely and without causing a significant immune response. Human trials will need to demonstrate the technology can live up to its disruptive potential.

Interviews Gene Therapy

Asia Deal Watch: Junshi, Rxilient Form Joint Venture Around Toripalimab

Plus deals involving Biorchestra, Takeda/F-star, TaiGen/Joincare, Dr Reddy’s/Eris, Kaken/bitBiome, CJ Bioscience/4D Pharma, Ono/Macomics, Daiichi Sankyo/Zymeworks, Celltrion/Genuv and more.

Deal Watch Business Strategies

EU Crunch Time For Mirikizumab, New COVID-19 Vaccine & Other Drugs

The European Medicines Agency’s human medicines committee, the CHMP, is this week deciding whether to back marketing approval for eight new drugs and a coronavirus vaccine.

Europe Drug Review
See All

Company Information

  • Industry
  • Medical Devices
UsernamePublicRestriction

Register